Hib Vaccines

First licensed in 1985, the Hib vaccine protects against H. influenzae type b (Hib), an invasive bacteria that causes epiglottitis, meningitis, pneumonia, septic arthritis, and cellulitis.

In the pre-vaccine era, Hib caused epiglottitis, meningitis, and pneumonia - all life-threatening diseases that are now prevented by the Hib vaccine.
In the pre-vaccine era, Hib caused epiglottitis, meningitis, and pneumonia – all life-threatening diseases that are now prevented by the Hib vaccine.

A newer Hib vaccine, which could be given to infants, was licensed in 1987

Now all children get their first dose of the Hib vaccine when they are two months old, complete a two to three dose primary series over the next two to four months, and get a booster dose when they are 12 to 15 months old.

More on Hib Vaccines

Last Updated on

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.